Two new studies report specific mechanisms of impaired type I interferon (IFN) signaling in some hospitalized patients suffering from severe cases of COVID-19, suggesting that screens for these defects could help identify patients at the highest risk of life-threatening complications from SARS-CoV-2 infection.
The results of the paired studies - which report that mutations in type I IFN-associated genes and high titers of neutralizing autoantibodies against type I IFNs may both be associated with severe COVID-19 respiratory symptoms - also suggest that administering specific type I IFNs to select high-risk patients could offer therapeutic benefits, especially early in the course of the disease.
To test whether severe COVID-19 respiratory symptoms may be associated with the genetics of type I IFN signaling, the authors performed whole-genome or whole-exome sequencing of 659 patients hospitalized with life-threatening COVID-19 pneumonia and 534 patients with asymptomatic or mild infection. Focusing on 13 gene loci known to govern TLR3- and IRF7-dependent type I IFN immunity to influenza virus, the researchers found rare loss-of-function gene variants in 3.5% of the patients with severe COVID-19 symptoms, but not in the asymptomatic/mild cohort. This subgroup of patients (23 in total) ranged in age from 17 to 77, with representation of both sexes and various ancestries.
Based on their findings, the researchers suggest that mutations in other type I IFN-related genes may exist in other patients with life-threatening COVID-19 symptoms. In a related study,
In the second study the authors investigated whether neutralizing autoantibodies (which aberrantly recognize, bind to, and neutralize a patient's own proteins) against type I IFNs might also underlie severe COVID-19 pneumonia. In a screen of 987 patients with dire cases of COVID-19, the researchers found that 101 patients had autoantibodies against IFN-ω, IFN-a, or both. In contrast, 663 patients with asymptomatic or mild cases of COVID-19 had none of the autoantibodies, and only 4 of 1,227 healthy individuals, sampled before the pandemic, had one or more of the autoantibody types.
Based on their findings, the authors. conclude that "the neutralizing [autoantibodies] against type I IFNs, like inborn errors of type I IFN production, tip the balance in favor of the virus, resulting in devastating disease, with insufficient, and even perhaps deleterious, innate and adaptive immune responses."
https://www.niaid.nih.gov/news-events/scientists-discover-genetic-and-immunologic-underpinnings-some-cases-severe-covid-19
https://science.sciencemag.org/content/early/2020/09/23/science.abd4570
https://science.sciencemag.org/content/early/2020/09/23/science.abd4585
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Finborn-errors-of-type-i&filter=22
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fauto-antibodies-against&filter=22
Impaired type I interferon signaling may contribute to severe COVID-19 symptoms
- 523 views
- Added
Edited
Latest News
Linking endosomal trafficking to aggressive brain cancer
Overactive food quality control system triggers food allergies
How plants produce defensive toxins without harming themselves
Artificially infect mosquitoes with human malaria to identify new chemicals
Basophil-neuronal axis in acute itch in eczema
Other Top Stories
Teamwork between cells fuels aggressive childhood brain tumor
Role of extracellular matrix protein in breast cancer growth
Increasing esophageal cancer therapeutic efficacy using infrared nanoparticles
Mapping DNA damage links to onset of skin cancer
Crystal structure reveals how curcumin impairs cancer
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
An Arf/Rab cascade controls the growth and invasiveness of glioblastoma
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV P…
MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degen…
Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Presentations
Homeostasis
PLANT MITOCHONDRIAL BIOLOGY
Photosynthesis
Endocrine Disorders
THE PITUITARY GLAND
Posters
ACMT 2020 Annual Scientific Meeting Abstracts - New York, NY
Abstracts from the 2020 Annual Scientific Meeting of the British and Irish Hypertension Society (…
ACNP 58th Annual Meeting: Poster Session III
ACNP 58th Annual Meeting: Poster Session II
ACNP 58th Annual Meeting: Poster Session I